Company Filing History:
Years Active: 1994-2002
Title: Innovations in HPV Detection by Petrus Josephus Snijders
Introduction
Petrus Josephus Snijders is a notable inventor based in the Netherlands. He has made significant contributions to the field of medical diagnostics, particularly in the detection of human papillomavirus (HPV), which is a major risk factor for cervical cancer. His innovative approach has the potential to enhance early detection and improve patient outcomes.
Latest Patents
Petrus Josephus Snijders holds a patent for a new detection method for cervical HPVs. This invention describes a consensus PCR-based method, known as HRE7-PCR, for the simultaneous detection of 14 high-risk HPV types. These types include HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, as well as a candidate high-risk type, HPV 67. The method utilizes sets of 6 overlapping forward primers and 9 overlapping backward primers to amplify a fragment of approximately 215 to 245 base pairs of the E7 open reading frame of these HPV types. For the detection of reaction products, an EIA format can be employed with the aid of a cocktail of type-specific oligoprobes. Additionally, he has developed a method for efficient typing of these 15 HPVs, which is compatible with the detection method.
Career Highlights
Petrus Josephus Snijders is associated with Self-screen B.V., where he continues to work on innovative solutions in HPV detection. His expertise in molecular biology and diagnostics has positioned him as a key figure in the fight against cervical cancer.
Collaborations
Petrus collaborates with Christophorus Joannes Meijer, contributing to advancements in HPV detection methodologies.
Conclusion
Petrus Josephus Snijders is a pioneering inventor whose work in HPV detection is crucial for improving cervical cancer diagnostics. His innovative methods have the potential to significantly impact public health and patient care.